drugset / Trial / NCT00624013

Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life.

NCT00624013

Phase 4 Completed 89 enrolled Charles Drew University of Medicine and Science
RandomizedParallel-groupTriple-blindTreatment

Summary

This proposed study will test the following hypothesis: Treating depression in Hispanics and African Americans with diabetes will improve their HbA1c and quality of life while on intervention and six months after intervention.

Timeline

Start
2006-09
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sertraline Small molecule 50 mg
Comparator Sertraline Small molecule 100 mg